6c3fd2dd__Trials_Monthly___October_2013__Description
[NCI Designation] NCT01709734 [Disease Site] Prostate Cancer [Description] 
ARMOR2: A 2 Part, Phase II Trial of Galeterone in the Treatment of Castration-Resistant Prostate Cancer
Seattle Cancer Care Alliance | Clinical Trials Monthly - October 2013
Description